Business Wire

Sparrow Pharmaceuticals Presented New Data on Clofutriben and Prednisolone for Polymyalgia Rheumatica Treatment at DGRh Kongress 2024

PORTLAND, Ore.--(BUSINESS WIRE)--Sparrow Pharmaceuticals today announced that it presented new data from its ongoing Phase 2 clinical trial of its HSD-1 inhibitor, clofutriben (referred to SPI-62 in ...
Morningstar

Novartis's Cosentyx Meets Targets for the Treatment of Polymyalgia Rheumatica

Novartis said that its immunology drug Cosentyx met the primary target and all secondary ones in a late-stage trial for the treatment of patients with inflammatory disease polymyalgia rheumatica.
Business Wire

Sparrow Pharmaceuticals to Present Two Abstracts at ACR Convergence 2024 and Expand Phase 2 Clinical Trial of Clofutriben with Prednisolone for Polymyalgia Rheumatica to Fifth ...

PORTLAND, Ore.--(BUSINESS WIRE)--Sparrow Pharmaceuticals, a clinical-stage biopharmaceutical company that develops novel, targeted therapies to address unmet needs in both endocrinology and ...
RheumatoidArthritis.net

Differentiating Polymyalgia Rheumatica (PMR) From Elderly-Onset Rheumatoid Arthritis (EORA)

Struggling with joint pain? Learn how to tell polymyalgia rheumatica (PMR) vs EORA apart through blood tests and imaging. Discover the path to treatment.